The meeting has been conceived along two axes: the first axis is Technologies: Cellular Therapy, Biologics, Small Molecules, Artificial Intelligence and Precision Theragnostics. The second axis is the translational and clinical experiences and advancements in the areas of Cancer and Autoimmunity. These two axes interlace to depict how we are exploiting state-of-the-art technology to manipulate immunity for effective therapeutic control. We chose Autoimmunity and Cancer as the extremes of the gradient of immune reactivity.
The meeting caters to a broad audience, ranging from trainees to leaders in the field. It is meant to provide knowledge in the hottest field in medicine, to inspire new ideas and to catalyse and sparkle collaborations.
Subscribe to our mailing list to get the updates to your inbox